Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership2,189,256 shares
Latest Disclosed Value $ 7,839,361
Geode Capital Management, Llc reports 3.25% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 2,189,256 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $6,162,756 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,120,269 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 3.25% during the quarter. The current value of the position is $5,341,785 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,189,256 68,987 3.25 7,839 5.32 0.0003
2026-02-09 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,120,269 205,715 10.74 7,443 19.24 0.0005
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,914,554 -116,337 -5.73 6,243 25.44 0.0004
2025-08-08 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,030,891 36,847 1.85 4,976 -62.59 0.0003
2025-05-13 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,994,044 241,069 13.75 13,303 -39.64 0.0010
2025-02-12 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,752,975 135,109 8.35 22,041 -26.26 0.0017
2024-11-12 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,617,866 14,256 0.89 29,888 -13.45 0.0024
2024-08-09 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,603,610 101,023 6.72 34,533 -14.71 0.0030
2024-05-13 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,502,587 45,337 3.11 40,487 -7.31 0.0037
2024-02-13 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,457,250 217,090 17.50 43,679 71.87 0.0046
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,240,160 56,057 4.73 25,414 8.02 0.0030
2023-08-11 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,184,103 28,364 2.45 23,528 18.85 0.0028
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,155,739 54,419 4.94 19,798 94,171.43 0.0026
2023-02-13 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,101,320 242,101 28.18 22 -99.85 0.0030
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 859,219 50,756 6.28 13,713 23.27 0.0021
2022-08-12 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 808,463 59,726 7.98 11,124 -6.32 0.0016
2022-05-13 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 748,737 -5,890 -0.78 11,874 -27.92 0.0015
2022-02-11 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 754,627 2,766 0.37 16,473 -26.70 0.0020
2021-11-12 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 751,861 9,974 1.34 22,473 -31.61 0.0030
2021-08-13 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 741,887 55,498 8.09 32,858 7.89 0.0045
2021-05-12 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 686,389 85,749 14.28 30,455 -7.54 0.0047
2021-02-12 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 600,640 69,608 13.11 32,939 171.35 0.0055
2020-11-13 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 531,032 -18,016 -3.28 12,139 5.64 0.0024
2020-08-13 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 549,048 29,592 5.70 11,491 58.58 0.0025
2020-05-14 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 519,456 51,151 10.92 7,246 -32.01 0.0019
2020-02-20 2019-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 468,305 3,654 0.79 10,658 96.90 0.0022
2020-02-13 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 468,305 3,654 10,658 1,358.2686
2019-11-12 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 464,651 20,837 4.69 5,413 -18.69 0.0013
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 443,814 112,660 34.02 6,657 14.62 0.0016
2019-05-14 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 331,154 34,122 11.49 5,808 31.94 0.0015
2019-03-06 2018-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 297,032 74,923 33.73 4,402 -19.50 0.0014
2019-02-13 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 297,032 74,923 4,402
2018-11-13 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 222,109 84,135 60.98 5,468 101.92 0.0015
2018-08-14 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 137,974 57,496 71.44 2,708 79.58 0.0008
2018-05-15 2018-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 80,478 80,478 1,508 0.0005
2018-02-13 2017-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -102,964 -100.00 0 -100.00
2017-11-14 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 102,964 0 0.00 183 -6.15 0.0001
2017-08-14 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 102,964 -31,365 -23.35 195 -27.24 0.0001
2017-06-21 2017-03-31 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 134,329 3,510 2.68 268 -66.37 0.0001
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 134,329 268
2017-02-14 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 130,819 5,857 4.69 797 -32.69 0.0004
2016-11-10 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 124,962 21,661 20.97 1,184 54.17 0.0006
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 103,301 21,229 25.87 768 26.52 0.0004
2016-05-13 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 82,072 -54 -0.07 607 -34.73 0.0003
2016-02-12 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 82,126 2,929 3.70 930 25.00 0.0005
2015-11-13 2015-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 79,197 49,588 167.48 744 413.10 0.0005
2015-08-14 2015-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 29,609 29,609 145 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.